Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis”

8 trials

Showing 8 of 8 results

Testing effectiveness (Phase 2)Study completedNCT05638737
What this trial is testing

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Who this might be right for
Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 112
Testing effectiveness (Phase 2)Study completedNCT05364931
What this trial is testing

Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
AstraZeneca 54
Large-scale testing (Phase 3)Looking for participantsNCT06215716
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Who this might be right for
NASH With FibrosisMASH With Fibrosis
Akero Therapeutics, Inc 1,650
Testing effectiveness (Phase 2)UnknownNCT04880187
What this trial is testing

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Axcella Health, Inc 273
Early research (Phase 1)Ended earlyNCT05864391
What this trial is testing

Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.

Who this might be right for
Steatohepatitis
AstraZeneca 40
Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Large-scale testing (Phase 3)Active Not RecruitingNCT04849728
What this trial is testing

Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma 1,000
Testing effectiveness (Phase 2)Study completedNCT05809934
What this trial is testing

Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Nonalcoholic Steatohepatitis
AstraZeneca 220

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation